News and Announcements
Alcidion and Calvary Health Care Collaborate
- Published March 07, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Alcidion Group Limited (ASX:ALC) today announced that it has signed an agreement with the Little Company of Mary Health Care (LCMHC, ‘Calvary)’ to assist the organisation with streamlining clinical coding and patient data across their facilities.
KEY TAKEAWAYS:
- Calvary Health Care operates 15 Public and Private Hospitals, 15 Retirement and Aged Care Facilities;
- A national network of Community Care Centres across six States and Territories in Australia;
- Calvary’s strategy includes the innovative use of technology and services to support new models of care that are patient-centric and sustainable.
Ray Blight, CEO and Chairman of Alcidion Group Limited said “We are delighted that Calvary has selected Alcidion to assist them in identifying opportunities for innovation and service improvement. Calvary’s Data Lake will provide the evidence for innovation opportunities and this will help drive future service improvements”.
Dr. Robin Mann, National Chief of Innovation, who leads Calvary’s digital transformation; commented, “The Data Lake forms an integral part of our innovation strategy moving forward and I look forward to working with Alcidion over the coming months.”
Alcidion Group Limited (ASX:ALC) is a publicly listed, innovative health informatics company that specializes in clinical products that improve productivity, safety and efficiency. Alcidion’s solutions target key problems for Emergency Rooms, Inpatient Services and Outpatient Departments and are built upon a next generation health informatics platform.
Company Updates
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Asset over thematic: Centuria’s Andrew Essey warns against ‘blanket strategies’ as global capital eyes Australia
Relying solely on broad macroeconomic trends is the single biggest mistake property investors make today. Centuria Capital CIO Andrew Essey explains why asset-level “lettability” always trumps the overarching sector thematic, and reveals where global institutional capital is quietly pivoting to capture high-octane returns.
Backed By Leading Investment Groups and Family Offices
